Patent protection is narrower than the phrase suggests, and it costs more than most owners expect.
What it gives you is the ability to stop other people. Not permission to act yourself.
Where it applies is one country at a time. A US patent restrains nothing in Germany.
And it lasts only while you keep paying. Which is why 58.6% of US utility patents end before their term does.
What the protection is
| Protection covers | Protection does not cover |
|---|---|
| Making the claimed invention | Your own right to practise |
| Using it | Anything outside the claims |
| Selling it | Activity in countries where you hold no patent |
| Offering it for sale | Ideas, as opposed to claimed inventions |
| Importing it | Independent invention by you of someone else's claim |
Each activity is independent. Importing an infringing product infringes even where it was manufactured lawfully abroad.
Offering for sale counts alone. A price list can infringe with no product changing hands.
The right to exclude is not a right to practise
| Situation | Result |
|---|---|
| You patent an improvement | Valid |
| Someone holds a patent on the base invention | Also valid |
| Your improvement requires the base | You infringe theirs |
| They cannot practise your improvement | They infringe yours |
| Outcome | Cross-licence, or neither ships |
Blocking positions are ordinary, not a defect. Improvement patents that cannot be practised without a licence to the underlying invention exist in every field.
A grant is not clearance. Freedom to operate is a separate analysis and it is the one that determines whether you can sell. See freedom to operate.
Protection is national
| Patent granted by | Protects in |
|---|---|
| USPTO | The United States only |
| EPO, then validated | Each validated state separately |
| CNIPA | China only |
| Nowhere | Nowhere |
There is no world patent. The PCT defers national decisions; it grants nothing.
Manufacturing jurisdictions are undervalued. Coverage where a product is made can stop the supply chain rather than chasing distribution.
European patents fragment at grant, creating separate national rights with separate annuities. See patent annuity fees by country.
Duration
| Type | Term | Fees |
|---|---|---|
| Utility | 20 years from earliest non-provisional filing | Three |
| Design | 15 years from grant | None |
| Plant | 20 years from filing | None |
| Adjustment | Effect |
|---|---|
| Patent Term Adjustment | Adds days for USPTO delay |
| Patent Term Extension | Up to 5 years, regulated products |
| Terminal disclaimer | Caps the term |
| Continuation chain | Runs from the earliest parent |
Continuations are the common miscalculation. A patent filed in 2024 from a 2016 parent expires in 2036, not 2044.
No patent can be renewed beyond its term. Maintenance fees keep it alive within the term; they do not extend it. See can you renew a patent.
Protection abroad requires separate action
| Step | Deadline |
|---|---|
| Paris Convention filing | 12 months from priority |
| PCT national stage | ~30 months from priority |
| Public disclosure before filing | Forfeits rights, most countries |
| Validation after EPO grant | Per state, short window |
| Annuities | Annual, per country |
The twelve-month deadline is unforgiving and it is the point at which most foreign protection is lost by default rather than by decision.
What it costs to keep
| Fee | Due after grant | Large | Small (40%) | Micro (20%) |
|---|---|---|---|---|
| First | 3.5 years | $2,150 | $860 | $430 |
| Second | 7.5 years | $4,040 | $1,616 | $808 |
| Third | 11.5 years | $8,280 | $3,312 | $1,656 |
| Total | $14,470 | $5,788 | $2,894 |
| Plus | Detail |
|---|---|
| Cost to obtain | $8,000–$20,000 including professional fees |
| Foreign annuities | Annual, per country |
| Enforcement | Millions, if pursued |
| Monitoring | Ongoing |
The escalating schedule forces re-evaluation three times, which is exactly what it is designed to do.
What the market concludes
| Ipiry Patent Survival Curve v1.0 | Rate |
|---|---|
| Survive the 3.5-year fee (2022 cohort) | 85.8% |
| Survive the 7.5-year fee (2018 cohort) | 64.6% |
| Reach full term (2014 cohort) | 41.4% |
| Abandoned before full term | 58.6% |
| Lost at the first fee | 14.2% |
| Lost at the third fee | 23.2 points |
| Conditional: paid first two, pay third | 63.0% |
Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.
Nearly three in five owners decide the protection is not worth its cost. That is not failure; it is the schedule working.
The conditional figure is the sharper one. Of patents already funded through two windows, more than a third are still released at the third.
What protection covers over time
| Phase | Protection |
|---|---|
| Pre-filing | None |
| Pending | None enforceable |
| Granted, fees current | Full |
| In a grace period | Still in force |
| Lapsed | None — revival may be possible |
| Expired | None, permanently |
Protection is not continuous by default. It requires three affirmative payments across a patent's life, each of which is a decision rather than an invoice.
A patent in its grace period is still enforceable, which matters when timing a launch or a negotiation against someone else's asset.
Protection before grant
| Stage | Enforceable protection |
|---|---|
| Idea | None |
| Provisional filed | None — a priority date only |
| Non-provisional pending | None |
| Published at 18 months | Provisional rights, narrowly |
| Granted | Full right to exclude |
"Patent pending" confers no rights. It signals an application exists, which has deterrent value and no legal force.
Provisional rights require actual notice and granted claims substantially identical to the published ones, so they rarely produce recovery in practice.
The claims decide the protection
| The description | Explains the invention |
| The claims | Define the protection |
| Broad claims | More protection |
| Narrow claims | Easily designed around |
| Invalidated claims | No protection at all |
A patent with narrow claims covering an approach nobody uses protects nothing anyone wants to do. Reading the claims is how you find out what you actually have. See patent claim.
Enforcing protection
| Requirement | Detail |
|---|---|
| Standing | Owner, or a licensee with substantially all rights |
| Patent in force at the time | Of the infringement |
| Marking | Limits damages if products are unmarked |
| Six-year cap | On past damages |
| Cost | Millions, if litigated |
| Risk | The patent can be invalidated |
Protection you will not enforce is protection in name. That is a legitimate position where the deterrent value is real, and it should be an assessed one.
Marking is the cheap step that preserves damages. See patent marking.
Alternatives and complements
| Route | Protects | Duration |
|---|---|---|
| Trade secret | An undetectable process | Indefinite, while secret |
| Trademark | The brand | Indefinite with renewal |
| Copyright | Specific code and content | Long |
| Design patent | Appearance | 15 yrs, no fees |
| Defensive publication | Stops others patenting it | Permanent, very cheap |
| Contracts | Relationships | As agreed |
Trade secret is the strongest alternative for undetectable processes, and filing forecloses it permanently. Publication at eighteen months destroys secrecy whether or not a patent grants.
Defensive publication is underused where the concern is being blocked rather than blocking others.
Independent creation is a defence to trade secret and copyright but not to patents, which is what makes patent protection unusually strong and freedom-to-operate work necessary.
Protection across a product
| Aspect | Protection | Duration |
|---|---|---|
| The mechanism | Utility patent | 20 yrs from filing, three fees |
| The appearance | Design patent | 15 yrs from grant, no fees |
| The name | Trademark | Indefinite with renewal |
| Manuals and software | Copyright | Long |
| Manufacturing process | Trade secret | While secret |
No single right covers a product. Layering them is normal, and each runs on its own clock with its own failure modes.
The trademark frequently outlasts everything else. It protects what customers recognise, and it renews indefinitely.
Worked example: protection assessed honestly
A small company holds one US patent, 7 years remaining, small entity.
| Question | Answer |
|---|---|
| Do we sell a product using it? | No — the line was discontinued |
| Does anyone else practise the claims? | Screened: no |
| Would we enforce if they did? | No budget |
| Does it block a competitor? | Not identifiably |
| Remaining fees | $4,928 |
| Foreign members | None |
| Option | Outcome |
|---|---|
| Keep paying | −$4,928 for protection over nothing |
| Sell | 7 years is saleable; worth trying |
| License | No licensee exists |
| Release | Ends the cost, captures nothing |
Protection over something nobody does is not protection. It is a subscription.
The right sequence is sell first, release if that fails, and starting twelve months before the deadline is what keeps the first option open. See patent monetization.
Protection is not automatic after grant
| Requirement | Consequence if missed |
|---|---|
| Pay three maintenance fees | Patent expires early |
| Keep entity status accurate | Can render it unenforceable |
| Mark products | Damages limited to notice date |
| Record assignments | Blocks sale, and foreign renewals |
| Monitor for infringement | Six-year damages cap runs regardless |
Entity status is checked at each payment, not set once. Growth or a licence to a large company ends small entity eligibility. See small entity status.
Reviewing protection you hold
| Check | When |
|---|---|
| Is it in force? | Before relying on it |
| Do the claims cover anything current? | Annually |
| Does anyone practise them? | Free screening |
| Would you act on infringement? | Honestly |
| Fees against value | Each window |
| Foreign members still relevant? | Each annuity |
Phrase each fee window as a decision, not a payment. See patent portfolio management.
Patent protection: the checklist
- It is a right to exclude, never a right to practise.
- Run freedom-to-operate work separately. A grant is not clearance.
- All five activities count — make, use, sell, offer, import.
- Protection is national. File where the market and manufacturing are.
- Read the claims. They define what you actually protect.
- Calculate term from the earliest non-provisional filing in the chain.
- Budget the full maintenance cost — up to $14,470 in the US alone.
- Nothing enforceable exists before grant. "Patent pending" is a signal.
- Consider trade secret seriously, since filing forecloses it permanently.
- Re-test annually whether the protection covers anything anyone does.